UCL Cancer Institute
The UCL Cancer Institute
Based at University College London, one of the world’s top universities, the UCL Cancer Institute is rapidly developing as one of the UK’s leading cancer research centres. The Institute draws together over 300 talented researchers and clinicians who are working together to translate research discoveries into new strategies to prevent, diagnose and treat cancer.
The Cancer Institute is affiliated with leading teaching and specialist hospitals in central London, including University College Hospital London (UCLH), Royal Free Hospital and Great Ormond Street Hospital. Particular areas of strength include clinical trials, research into childhood cancer and cancers affecting teenagers, haematological malignancies (including leukaemia and lymphoma), lung, liver, brain cancers and sarcoma. Reflecting its focus on translational work, the Institute is also the nucleus for the UCL Cancer Research UK Centre and the UCL Experimental Cancer Medicine Centre.
Professor Tariq Enver
Director, UCL Cancer Institute
“We are at the dawn of the most exciting time in the history of cancer research and treatment. New targeted therapies are resulting in major clinical responses, and molecular markers, circulating tumour cells, as well as molecular imaging will be applied to stratify patients to the best therapies, sparing patients unnecessary toxic therapies, and facilitating evaluation of responses early during treatment to determine whether patients are responding to specific therapy.
Molecular profiles, including whole genome sequencing information, will determine in the near future the best treatment for each individual patient, as well as helping to predict the likely outcome and adverse affects.”
Page last modified on 21 may 13 10:03